Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01121146 · ClinicalTrials.gov registry record · NA

Study Comparing Marathon Polyethylene and Enduron Polyethylene Acetabular Liners Used in Total Hip Arthroplasty

A NA study of Osteoarthritis and Arthritis, sponsored by Anderson Orthopaedic Research Institute.

Completed
Registry status
NA
Development phase
236
Enrollment target
1
Study location

NCT01121146 is a NA study of Osteoarthritis and Arthritis that has completed, run by Anderson Orthopaedic Research Institute. The registered enrollment target is 236 participants, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01121146, a NA study of Osteoarthritis and Arthritis, has completed, sponsored by Anderson Orthopaedic Research Institute.

COMPLETED
Registry status
NA
Development phase
236 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine whether crosslinked Marathon and standard Enduron polyethylene liners show differences in bone loss around the hip implant.

Interventions

  • DEVICE Total Hip Replacement

Study Locations (1)

Virginia

  • Anderson Orthopaedic Research Institute - Alexandria

Trial Details

FieldValue
Enrollment Target 236 participants
Start Date 1998-12
Est. Completion 2012-03
Phase NA

What the Registry Record Tells You About NCT01121146

The ClinicalTrials.gov registry entry for NCT01121146 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 236 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (71% lower). The listed sponsor is Anderson Orthopaedic Research Institute, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Total Hip Replacement is the first listed.

NCT01121146 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT01121146 about?

NCT01121146 is a clinical study titled "Study Comparing Marathon Polyethylene and Enduron Polyethylene Acetabular Liners Used in Total Hip Arthroplasty". The purpose of the study is to determine whether crosslinked Marathon and standard Enduron polyethylene liners show differences in bone loss around the hip implant.

What is the current status of trial NCT01121146?

This trial is currently completed. It is a NA study. The enrollment target is 236 participants. The study started on 1998-12. Estimated completion is 2012-03.

What conditions does trial NCT01121146 study?

This clinical trial studies the following conditions: Osteoarthritis, Arthritis, Musculoskeletal Diseases, Rheumatic Diseases, Joint Diseases.

What interventions are being tested in trial NCT01121146?

The interventions under investigation include: Total Hip Replacement (DEVICE).

Who is sponsoring clinical trial NCT01121146?

This trial is sponsored by Anderson Orthopaedic Research Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01121146 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.